The major histocompatibility complex (MHC) class I antigens are generally ubiquitously expressed and provide the identity to the host organism.
1,2 Expression of these antigens on the cell surface requires the concerted action of multiple proteins, which are part of the antigen processing machinery, including the transporters associated with antigen processing (TAP) 1 and 2, the low molecular mass polypeptide (LMP), tapasin, and so on, 3, 4 which process the class I antigens in the endoplasmic reticulum (ER), after which the correctly folded heavy chain (class I molecules themselves) associates with the light chain (b2M molecules) and are together transported to the cell surface. 5 The proper expression thus results in the eventual presentation of the self/foreign peptides at the cell periphery, facilitating T-lymphocyte recognition.
Correlation between levels of MHC class I expression and pathological conditions have been demonstrated. Hypoexpression of class I molecules on the cell surface have been observed in many tumor cells due to various mechanisms including methylation of the heavy chain genes, defects in b2M expression, defects in TAP or LMP expression, and so on, hence leading to their escape from immune surveillance by the cytotoxic T cells. 6 Reintroduction of the missing MHC class I genes in many mouse tumor models resulted in the susceptibility of tumor cells to immune destruction, 7 demonstrating a crucial role for the expression of MHC class I genes in enabling the recognition by T cells. On the contrary, elevated expression of the MHC class I antigens leads to recognition and destruction by the immune T cells, as demonstrated in autoimmune diseases. 8 Transgenic overexpression of class I genes resulted in cellular defects such as developmental failure in chimeras; induction of insulindependent diabetes due to destruction of pancreatic b-cells; thyroid cell destruction; neural tube defects; disruption of lens development leading to cataract induction, and demyelination in oligodendrocytes. [9] [10] [11] [12] [13] Although many of the phenotypes observed were dependent on activating the immune system, some were independent of immune activation and often resulted in tissue destruction, suggesting that MHC class I expression may have other non-immunological functions regulating cellular growth. However, whether changes in class I expression levels affect the proper functioning of a cell (independent on the immune system) has not been critically analyzed.
We therefore tested the hypothesis that modulation of class I expression could directly affect cellular survival independent of the immune system. Our data indicate that cells lacking class I expression on the cell surface were resistant to a variety of apoptotic insults and had compromised p53 activation. Defective p53 was due to its sequestration in the cytoplasm. Cells lacking class I expression on the cell surface had elevated ER stress, which led to cytoplasmic sequestration of p53. These data therefore suggest that defects in MHC class I expression in tumors may provide not only escape from immune surveillance, but also confer survival advantage on tumor cells through the elevation of ER stress.
Results

b2M
À/À cells are resistant to cell death induced by genotoxic stress signals. Although sporadic reports have demonstrated that expression of MHC class I levels fluctuate during various physiological conditions, the relevance of such findings has not been fully understood. Hence, we first evaluated whether the absence of class I expression would affect cell death. As there are many class I antigens expressed in the cell, it is almost impossible to obtain cells devoid of all their expression. We therefore utilized primary mouse fibroblasts lacking b2M, in which surface expression of MHC class I antigens have been almost completely lost ( Figure 1a ).
14 b2M À/À and b2M þ / þ (wild type) primary embryonic fibroblast cells were derived from C57BL6/129 mouse embryos and tested for their sensitivity to nutrient deprivation and hypoxia, conditions prevalent in tumor masses in vivo. Cobalt chloride was used to induce hypoxia. Whereas wild-type cells were susceptible to apoptosis in both cases, as determined by annexin-V FITC and propidium iodide (PI) staining, b2M (Figure 1c, lower panel for quantification) . Similar results were also obtained with other cytotoxic agents such as doxorubicin, camptothecin, hydrogen peroxide, and g-irradiation, determined using similar methods and also by independent analysis of sub-G 1 DNA content (data not shown), indicating that expression of b2M is essential for optimal cell death.
To evaluate whether the surface expression of MHC class I antigens was required for optimal cell death, we utilized the pan MHC blocking antibody, W6/32, which has the ability to block surface expression of MHC class I antigens by virtue of recognition of a non-polymorphic epitope common to all HLA class I molecules. 15 Human primary fibroblastic cell line IMR90 was incubated with W6/32 antibody before UV irradiation. Incubation with W6/32 resulted in the loss of surface expression of the human MHC class I antigens, as detected with another pan HLA antibody (Figure 1d Thus, the data together indicate that the absence of b2M affects the apoptotic process through mechanisms independent of surface exposure of the MHC class I antigens.
p53 activation is affected in b2M
À/À cells. p53 is a major regulator of cellular death, and is often functionally inactivated in tumors. 16 Thus, we envisaged that loss of MHC class I expression leading to p53 inactivation could be one mechanism through which tumor cells acquire resistance to death, and hence, survive. Therefore, we next investigated whether b2M À/À cells, which are resistant to cell death have compromised p53 activity. Immunoblot analysis indicated that whereas p53 protein was induced by various stress signals in wild-type mouse primary fibroblasts, it was severely compromised in b2M Wild-type and b2M À/À MEFs were UV irradiated (40 J/m 2 ) for 6 or 18 h or treated with the endoplasmic stress inducer tunicamycin (10 mg/ml) for 18 h and the cells were stained with anti-p53-specific antibody or dapi to locate the nucleus. Immunofluorescence analysis was performed to determine the extent of p53 translocation into the nucleus upon UV irradiation (a). Tunicamycin treatment has been shown to result in p53 being present in the cytoplasm (and not translocate to the nucleus) and was used as a control. Between 150 and 200 cells were counted per field, and at least three independent fields were analyzed per experiment. The experiments were repeated at least four independent times. (b) Quantification of cells (average) with nuclear p53 out of the whole field of view from one representative experiment. (c) Both nuclear and cytoplasmic fractions were prepared from both cell types after UV irradiation for the indicated time periods and the levels of p53 was determined. Lamin and actin served as quality and loading controls for nuclear and cytoplamsic fractions, respectively À/À cells were UV irradiated and the location of endogenous p53 was monitored by immuno fluorescence after staining with p53-specific antibodies. p53, which was generally diffuse and almost undetectable in untreated wildtype cells was localized to the nucleus, starting at about 6 h and peaked at around 18 h post irradiation (Figure 3a, top  panel) . Whereas only 1.75% of the cells had p53 in the nucleus in untreated state, irradiation resulted in about 57-59% of the wild-type cell population containing nuclear p53 (Figure 3b ). Consistent with published findings, treatment of wild-type cells with tunicamycin (TM), an ER stress-inducing agent, did not result in nuclear accumulation of p53 (Figure 3a, top panel) . 18 However, irradiation of b2M
cells did not result in substantial nuclear accumulation of p53 at both the time points, leading only to about 12-16% of the b2M À/À cells containing nuclear p53 (Figure 3a , middle panel). These results thus indicate that p53 localization to the nucleus might be affected in b2M À/À cells, which could contribute to the defects in p53 activation in these cells.
To confirm this, we performed fractionation of cellular lysates and analyzed the p53 status in the cytoplasmic and nuclear fractions. As shown in Figure 3c , UV irradiation resulted in an increase in p53 levels in cytoplasm from 2-8 h and a consequent accumulation in the nucleus between 4-16 h in wild-type cells. By contrast, although p53 accumulated later in b2M À/À cells (between 16-24 h), there was a distinct absence of accumulation in the nuclear fraction ( Figure 3c , compare with loading controls). These data, together with the immunofluorescence results suggest that p53 translocation to the nucleus upon exposure to genotoxic stress such as UV irradiation is affected in the absence of b2M.
b2M
À/À cells display constitutively elevated ER stress. Sequestration of p53 in the cytoplasm could be due to several mechanisms, one of which is elevated ER stress, as has been recently demonstrated. 18 As the absence of b2M results in the improper folding of the MHC class I antigens (leading to defects in surface expression), we envisaged that this would lead to ER stress in these cells. We therefore tested whether the b2M À/À cells were subjected to constitutive ER stress. To this end, we employed several assays to determine the ER stress status. Firstly, the status of GRP78, which is activated by ER stress 19 was evaluated. Untreated wild-type cells did not express GRP78, which was induced by treatment with TM or another ER inducer, thapsigargin (TG) (Figure 4a ). By contrast, GRP78 expression was already detected in untreated b2M À/À cells, which were further robustly induced upon TM or TG treatment (Figure 4a) , suggesting that the b2M À/À cells are subjected to ER stress even in the absence of drug treatment. Next, we determined the status of XBP-1, which is also induced by ER stress. 20 Similar to GRP78, untreated b2M À/À cells expressed significantly higher basal levels of XBP-1 compared to their wild-type counterparts (Figure 4b , top panel). In both cell types, XBP-1 expression was induced upon treatment with TG or TM. XBP-1 is generally found in an unprocessed state and is processed by splicing of a small intron upon ER stress, giving rise to bands of different sizes upon Pst1 restriction enzyme digestion. 21 Analysis upon Pst1 digestion also revealed elevated levels of processed product from untreated b2M À/À cells compared to wild-type cells (Figure 4b, lower panel) . ER stress has also been shown to result in the phosphorylation and activation of the ER-resident kinase, PERK. 22 Analysis of phosphorylation status of PERK indicated that it was constitutively and robustly phosphorylated in b2M À/À cells compared to wild-type cells (Figure 4c ). The levels of total PERK was not affected, and treatment with TM or TG resulted in phosphorylation of PERK in wild-type cells, confirming its role in ER stress activation (Figure 4c ).
As ER stress was shown to inactivate p53 function due to the physical interaction with GSK-3b, leading to sequestration of p53 in the cytoplasm, 18 we tested whether p53 was constitutively bound to GSK-3b in b2M À/À cells. Immunoprecipitation with anti-p53 antibodies and subsequent immunoblot with anti-GSK-3b antibodies indicated that GSK-3b was only bound to p53 upon ER stress induced by TG in wild-type cells (Figure 4d ). However, GSK-3b was found to be bound to p53 in the untreated state in b2M À/À cells (Figure 4d ), indicative of elevated ER stress in these cells. The total levels of GSK-3b were equal in both cell types, thereby excluding any alterations in GSK-3b levels in b2M
À/À cells that may have contributed to the observations (Figure 4d, lower panel) .
To further confirm these observations, we performed immunofluorescence studies to evaluate the localization of GSK-3b, which was shown to be enriched upon ER stress. 18 Consistently, we found that GSK-3b was diffused in untreated cells and was enriched in the nucleus upon TG treatment in wild-type cells (Figure 4e, left panel) . However, GSK-3b was found both in the nucleus and the cytoplasm of untreated b2M À/À cells to a higher extent (Figure 4e , right panel). To substantiate this observation, we utilized nuclear and cytoplasmic fractions from cells of both genotypes and found that GSK-3b levels were indeed elevated in the nuclear fraction of b2M À/À cells compared to wild-type cells (Figure 4f ; compared with loading control). As expected, more p53 was seen in the nuclear fraction of wild-types cells in contrast to b2M À/À cells after UV irradiation (Figure 4f) . Thus, the data together suggest that the absence of b2M results in constitutively elevated ER stress, thereby probably leading to the sequestration of p53 in the cytoplasm.
Loss of MHC class I expression due to TAP deficiency also results in defects in apoptosis, p53 activation and elevated ER stress. To evaluate whether the lack of class I expression due to other defects in the MHC processing pathway would also result in a similar phenotype, we employed the mouse RMA and RMAS isogenic tumor cells that are proficient or deficient in TAP expression, respectively. 23 TAP has been demonstrated to be required for the efficient expression of MHC class I on the cellular surface. 24 Flow cytometric analysis confirmed that RMAS cells have a significant reduction of surface expression of the analysis of GRP78 was performed using mRNA from untreated or cells treated with thapsigargin (TG; 1 mM), tunicamycin (TM; 10 mg/ml), or UV irradiation (UV; 40 Jm À2 ) for 6 h. Gapdh serves as loading control. (b) RT-PCR analysis was performed to evaluate the levels of XBP-1, as described above (upper panel). Duplicate samples were used from each set. The XBP-1 PCR product was isolated and digested with Pst-1 restriction enzyme, which distinguishes between the processed (300 bp) and unprocessed band (600 bp; lower panel). XBP-1 is processed upon endoplasmic reticulum stress. (c) Immunoblot analysis of phosphorylated or total PERK in these cells. (d) Whole cell extracts (WCE) from both wild-type and b2M À/À MEFs, which were treated with TG for the indicated time periods were used for immunoprecipitation with anti-p53 antibodies, and immunoblotted with either GSK-3b (upper panel) or p53 (middle panel) antibodies to determine the amount of GSK-3b bound to p53. Arrow indicates the position of GSK-3b. WCE from above cells were immunoblotted with anti-GSK-3b and p53 antibodies to determine total the amount of protein present (lower panel). (e) Immunofluorescence analysis was performed using untreated or cells treated with UV and TG to determine the localization of GSK-3b and p53, as described above. Dapi staining shows the position of nuclei. p53 serves as a positive control for effective UV irradiation, being mainly in the nucleus of wild-type but not b2M À/À cells. GSK-3b is more abundant in the b2M À/À cells. p53
cells were used as a negative control for the background staining with the p53 antibody. Additionally, cells were stained only with FITC or PE-conjugated secondary antibodies as controls. (f) Both nuclear and cytoplasmic fractions were prepared from both cell types after UV irradiation or TG treatment and the levels of p53 or GSK-3b were determined, as described above g-irradiation was also compromised in RMAS cells compared to RMA cells (Figure 5c ). Analysis of ER stress markers such as XBP-1 levels indicated that untreated RMAS cells contained higher levels of XBP-1 compared to RMA cells (Figure 5d , left top panel). Moreover, Pst1 restriction digestion experiments indicated that RMAS cells contained significantly higher levels of processed products even in unstressed state (Figure 5d , left middle panel). In addition, western blot analysis confirmed that RMAS cells expressed higher XBP-1 protein even without any ER stress inducers (Figure 5d, right panel) . Taken together, the data indicate that absence of MHC class I expression due to defects in various mechanisms result in elevated ER stress and consequently, defective p53 activation and resistance to apoptosis.
Discussion
The data presented here demonstrate that the defects in MHC class I surface expression result in elevated ER stress and defective p53 activation. This leads to resistance to multiple apoptotic stimuli, therefore conferring cellular survival advantage. These results thus identify a novel role for defects in MHC class I antigen expression in promoting cellular growth and survival by allowing escape from apoptotic pressure. Although sporadic reports have demonstrated that expression of MHC class I levels fluctuate during various physiological conditions, the relevance of such findings has not been fully understood. The data presented here show that reduced class I expression confers survival advantage in response to growth factor deprivation, hypoxia, and a variety of genotoxic stresses. It is to be noted that oncogene-mediated cellular transformation and subsequent tumorigenesis -in which conditions of hypoxia and nutrient deprivation prevail -are also associated with reduction in class I expression. [25] [26] [27] Conversely, treatment with genotoxic agents leading to cell cycle arrest was associated with increased class I expression. Supporting evidence comes from pathological conditions in which cells undergoing arrest or cell death have also been associated with increased MHC class I expression. For example, motoneurons and nigral dopaminergic neurons in the brainstem of adult rat which were vulnerable to neurodegeneration in diseases such as Parkinson's disease (PD) and amyotrophic lateral sclerosis display high levels of both MHC class I heavy chain and b2M mRNAs. 28 Moreover, MHC class I expression was elevated in microglia upon both ischemia and axonal degeneration. 29 Similarly, we have noted that overexpression of MHC class I molecules also lead to p53-dependent apoptosis in fibroblasts (data not shown). Thus, these evidences from physiological settings correlate surface MHC class I levels with cellular survival, supporting our observations using cultured cells.
Defects in MHC class I expression were found to result in ER stress, which led to defects in p53 activation due to cytoplasmic sequestration of p53. p53 is a known mediator of cell death, and functional inactivation often occurs in tumors. 16 Thus, loss of MHC class I expression leading to p53 inactivation may thus be one mechanism through which tumor cells acquire resistance to death, and hence survive. A recent report shows that downregulation of MHC class I expression correlated with poor prognosis in colon cancers is supporting this idea. 30 Besides, several reports have suggested a positive correlation between elevated ER stress and resistance to apoptosis, and between an increase in ER markers and carcinogenesis. Overexpression of GRP78 was shown to result in reduced apoptosis and higher colony survival upon genotoxic challenges, and has been associated with hepatocarcinogenesis and malignant breast lesions, and very recently, to be a predictor of chemoresistance. [31] [32] [33] [34] Moreover, PERK function was shown to be essential for cell survival following the exposure of cells to ER stress. 35 Furthermore, XBP-1 was also shown to be essential for survival under hypoxic conditions and is required for tumor growth. 36 Finally, reduction of expression of ER proteins correlated with lower viability after ionophore treatment. 37 Taken together, the evidence supports our proposal that defects in cell-surface MHC class I expression lead to resistance to apoptosis by elevating ER stress.
As p53 nuclear localization and consequently its activity is compromised due to lack of MHC class I expression, we also investigated whether lack of class I in b2M À/À mice would affect tumorigenicity. However, b2M À/À mice did not succumb to spontaneous tumors up to over 3 years unlike their p53 À/À counterparts (data not shown). This suggested that although p53 activation (such as apoptosis) is compromised in b2M À/À cells, it was not sufficient to allow the formation of spontaneous tumors in mice. This could be due to the requirement for a threshold of p53 activity that has to be maintained for tumor suppression (which was not breached in the b2M À/À mice) -implying that although p53 activity is compromised in b2M À/À mice, it is not sufficient enough to inhibit p53's tumor suppressive function. In this respect, we noted that not all p53-dependent functions, such as ras-mediated senescence of primary fibroblasts as well as basal cellular proliferation rates, were compromised by lack of b2M (data not shown). Thus, although the defects in MHC class I surface expression is not sufficient to promote tumorigenicity, its absence leading to resistance to apoptosis probably contributes to the tumorigenic process.
In conclusion, the data presented here suggest that defects in MHC class I expression often found in cancer cells may not only provide an avenue for escape from immune surveillance, but also directly result in their resistance to apoptotic stimuli, thereby allowing enhanced growth. Thus, the status of surface MHC class I levels in tumors may provide information on whether the tumors may respond well to cytotoxic drugs, and be of prognostic significance. In addition, future efforts aimed at identifying regulators of ER stress may have potential utility in treating class I deficient tumors.
Materials and Methods
Cell lines, transfections, treatment conditions, and plasmids. All cell lines used in this study were cultured in 10% fetal bovine serum containing DMEM. IMR90 human diploid fibroblasts were obtained from ATCC. RMA and RMAS cells were obtained from Dr. Hideo Yagita and grown as non-adherent cells in culture. Murine embryonic fibroblasts (MEFs) were isolated from E12.5 p53 À/À and b2M À/À embryos and as described and immortalized spontaneously according to the 3T3 protocol. 38 Cells were starved by culturing in medium containing 0.5% serum for 48 h, and subsequently, 20% FCS (final concentration) was added directly onto the dishes to release them into the cell cycle. Nutrient deprivation was achieved by culturing cells 0.1% serum containing medium without other amino acids and nutrients.
Cells were treated with the following stress signals for cell death and MHC class I analysis: UV irradiation (as indicated); g-irradiation (20 Gy); cobalt chloride (400 and 800 mM); vinblastine (15-30 mM); cisplatin (50-80 mM); TM (10 mg/ml), and TG (1 mM), for indicated time periods. Cells were treated with 25 mg/ml cyclohexamide to inhibit protein synthesis for the indicated time periods.
Immunoblot analysis. Immunoblot analysis was performed as described. 38 Cellular fractionation was performed using NE-PER nuclear and cytoplasmic extractions reagents (Pierce Biotech), according to the manufacturer's protocol. The following antibodies were used for immunoblot analysis: p53 (CM5 -Novocastra) and (IC12 -Cell Signaling), phospho-ser18, -ser 315, and -389 p53, GSK-3b (Cell Signaling), phospho-PERK (US Biologicals), MDM2, Puma, Cyclin G, XBP-1, PERK, p21, Tubulin (Santa Cruz), Lamin (Cell Signaling), and Actin (Sigma).
Immunoprecipitations were carried out using anti-p53 antibody (mixture of Ab-3 and Ab-4, Oncogene Sciences), and immunoblotted using anti-p53 (CM5 or IC12) or anti-GSK3b antibodies.
Flow cytometry and cell death assays. Flow cytometric analysis was performed to determine MHC class I surface expression, using either the anti-H-2K b or H-2K k (Pharmingen) antibodies. Cell-surface MHC class I expression was blocked by incubated with the anti-pan HLA-blocking antibody (W6/32) for 1 h, before analysis of HLA surface expression using another anti-pan HLA antibody (clone G46-2.6, Pharmingen).
Two independent cell death assays were employed in this study, namely PI staining of sub-G1 populations, and annexin-V staining. Sub-G1 population analysis representing dead cells was performed as for cell cycle status analysis. To detect annexin-V þ cells, cells were incubated with FITC-conjugated annexin-V (BD biosciences) and 50 mg/ml PI in binding buffer, and cells were analyzed by flow cytometry.
RNA analysis. Total RNA was extracted and utilized for reverse transcriptase-PCR (RT-PCR) analysis as described 39 using the following primers: GRP78 -for: . XBP-1 product was digested with Pst-1 restriction enzyme to determine the amount of processed or unprocessed products of 300 and 600 bp, respectively, as described. 21 Northern blot was performed using mouse p53 cDNA as a probe as described. 38 Immunofluorescence. Cells grown on cover slips were fixed in 4% paraformaldehyde/PBS and incubated with anti-p53 (mixture of Ab-3 and Ab-4), or anti-GSK3b antibodies, followed by incubation with the secondary antibody (FITC or PE-conjugated anti-mouse/rabbit IgG) before being mounted in mounting medium containing DAPI. Cells were counted by eye, and compared to negative controls such as those without primary antibody as well as with p53 À/À cells stained with anti-p53 antibody. Cells with signals above these negative controls were counted as positive events. Between 150 and 200 cells were counted per field, and at least three independent fields were analyzed per experiment. The experiments were repeated at least four independent times.
